Last reviewed · How we verify
NCT06607653
The Efficacy of Olfactory Training Intervention on Olfactory and Other Non-motor Symptoms in PD
NA trial testing Olfactory training in Parkinson Disease in 40 participants. Not yet recruiting.
10 March 2025
Quick facts
| Lead sponsor | Anhui Medical University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 25 September 2024 |
| Primary completion | 10 March 2025 |
| Estimated completion | 10 April 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Olfactory training
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
- Olfactory Disorder — all drugs for Olfactory Disorder →
- Olfactory Training — all drugs for Olfactory Training →
Sponsor
Anhui Medical University
Who can join
Adults 40 to 75, any sex, with Parkinson Disease or Olfactory Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To explore the efficacy of olfactory training on olfactory and other non-motor symptoms in PD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06607653
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Olfactory training
Trials testing the same drug.
- NCT06066307 — Olfactory Performance in Culinary Arts Students · Phase 4 · unknown
- NCT05912881 — Chemosensory Dysfunction and Recovery in Endoscopic Endonasal Skull Base Surgery · NA · completed
- NCT05421195 — Clinical Treatment Research of COVID-19-related Olfactory Dysfunction · NA · unknown
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Anhui Medical University trials
Trials by the same sponsor.
- NCT07403591 — Mapsd Dual-target cTBS (Auditory Cortex and M1) for Generalized Anxiety Disorder · NA · not yet recruiting
- NCT07112612 — Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer · not yet recruiting
- NCT07112599 — Study of Predicting Lymph Node Metastasis of High-risk Prostate Cancer by Artificial Intelligence Multi-omics Analysis · recruiting
- NCT07176468 — Personalized iTBS in Real-World Clinical Settings for Schizophrenia · NA · recruiting
- NCT07486804 — Effects of taVNS Combined With tACS on Adolescents With Non-Suicidal Self-Injury · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06607653 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Anhui Medical University
- Last refreshed: 23 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06607653.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing